The rewards can be improved blood sugar, reduced appetite, and increased weight loss, reducing the risk of obesity-related complications
How long does it take to start seeing results
"ICH Q7: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients." ICH Harmonised Guidelines, 2000.
Insulin therapy, delivered via subcutaneous (SC) injections or continuous subcutaneous insulin infusion (CSII) systems, remains indispensable, particularly in individuals with T1DM and those with progressive or inadequately controlled T2DM
Current evidence supports long-term use for sustained weight loss, especially for people with genetic predispositions to higher appetites
These changes not only promote weight loss but also support long-term metabolic health